SCHEDULE 13G

BridgeBio Oncology Therapeutics Inc

Common Stock · CUSIP: 107924102

Event date: 2025-09-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• BC Global Opportunities IX LP

  Shares: 4,365,747.00 · Class: 5.5%

• BC General Partner, LP

  Shares: 4,365,747.00 · Class: 5.5%

• BC Capital Management Limited

  Shares: 4,365,747.00 · Class: 5.5%

• Tan Kuangming

  Shares: 4,365,747.00 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.